Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Olba DVx Healthcare's Revenue for the
three
months ended in Jun. 2026 was 円30,818 Mil. Olba DVx Healthcare's average Accounts Receivable for the
three
months ended in Jun. 2026 was 円28,036 Mil.
Hence, Olba DVx Healthcare's Receivables Turnover for the
three
months ended in Jun. 2026 was 1.10.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Olba DVx Healthcare Receivables Turnover Related Terms
Olba DVx Healthcare Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Olba DVx Healthcare's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2689 vs MCK, COR, CAH: Receivables Turnover Comparison
For the Medical Distribution subindustry, Olba DVx Healthcare's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Olba DVx Healthcare Receivables Turnover vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Olba DVx Healthcare's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Olba DVx Healthcare's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Olba DVx Healthcare (TSE:2689) has a Receivables Turnover of 1.10 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Olba DVx Healthcare and its competitors. According to the industry distribution chart, Olba DVx Healthcare ranks #49 out of 122 companies in the Medical Distribution industry, placing it in the top 40.2%.
Is Olba DVx Healthcare's Receivables Turnover too high?
Olba DVx Healthcare's current Receivables Turnover is 1.10. The Medical Distribution industry median Receivables Turnover is 4.69. Olba DVx Healthcare's value of 1.10 is 76.5% below this industry median. Based on the distribution chart, Olba DVx Healthcare ranks #49 out of 122 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Olba DVx Healthcare has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olba DVx Healthcare's Receivables Turnover compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Olba DVx Healthcare ranks #49 out of 122 companies for Receivables Turnover. This puts Olba DVx Healthcare in the upper half of its industry. The industry median Receivables Turnover is 4.69. Olba DVx Healthcare's value of 1.10 is 76.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Distribution company?
The median Receivables Turnover among Medical Distribution companies is 4.69, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Olba DVx Healthcare's current Receivables Turnover of 1.10 is 76.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Olba DVx Healthcare and its competitors. For the Medical Distribution industry, the median Receivables Turnover is 4.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Olba DVx Healthcare's current Receivables Turnover is 1.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olba DVx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Olba DVx Healthcare (TSE:2689) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,165.13, compared to a current price of 円1,925.00 — trading 11.1% below its estimated fair value. The current Receivables Turnover is 1.10 and 76.5% below the Medical Distribution industry median of 4.69. Olba DVx Healthcare's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Olba DVx Healthcare (TSE:2689), the current Receivables Turnover is 1.10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olba DVx Healthcare (TSE:2689) Overvalued in 2026?
Based on GuruFocus' analysis, Olba DVx Healthcare stock appears to be undervalued.
The current stock price of 円1,925.00 is trading 11.1% below its estimated GF Value™ of 円2,165.13.
GuruFocus considers Olba DVx Healthcare to be Modestly Undervalued.
Key valuation signals for TSE:2689:
Receivables Turnover: 1.10
GF Value™: 円2,165.13 vs. price of 円1,925.00 (11.1% below fair value)
Industry Position: 76.5% below the Medical Distribution median (#49 of 122)
No single metric tells the full story. See the TSE:2689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
62GF Score
Get the complete analysis for TSE:2689
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2689 has been successfully added to your 
